All In Biotech

Drug Trial Radar · NCT06656988

A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE)

A Contrast Medium Sparing Strategy Using Automated Carbon Dioxide Injection During PERIpheral Vascular Interventions for PREVENTion of Major Adverse Kidney Events (MAKE): the PeriPREVENT Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Mar 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,960 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,960

Planned (sponsor's estimate)

Start

Apr 14, 2025

Primary completion

Feb 2028

Study completion Feb 2029

Sponsor

Lead sponsor
University of LeipzigAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the trial is to evaluate if an iodinated contrast medium sparing strategy using automated Carbon Dioxide (CO2) Injection prevents Major Adverse Kidney Events up to 90 days (MAKE90) in patients at moderately elevated risk for contrast-associated acute kidney injury (CA-AKI) undergoing infrainguinal peripheral vascular interventions (PVI).

Conditions

  • Peripheral Vascular Diseases
  • Kidney Diseases

Interventions

  • CO2Drug

    CO2 will be used as contrast medium sparing strategy during peripheral angiography

  • Iodinated Contrast Media (ICM)Drug

    Iodinated contrast medium will be used as in routine care during peripheral angiography

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. MAKE 90Time frame: From the day of the peripheral vascular intervention (day 0) to day 90

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • Tirol Kliniken Innsbruck

    Innsbruck, Austria · Recruiting

  • Universitätsklinik für Innere Medizin II

    Vienna, Austria · Recruiting

  • Kreiskrankenhaus Alsfeld

    Alsfeld, Germany · Recruiting

  • Universitäts-Herzzentrum Freiburg-Bad Krozingen

    Bad Krozingen, Germany · Recruiting

  • Universitätsklinikum Bonn

    Bonn, Germany · Not yet recruiting

  • Klinikum Chemnitz gGmbH

    Chemnitz, Germany · Not yet recruiting

  • DIAKO Krankenhaus gGmbH Flensburg

    Flensburg, Germany · Not yet recruiting

  • MVZ CCB Frankfurt und Main-Taunus GbR

    Frankfurt a.M., Germany · Recruiting

  • Universitätsklinikum Leipzig

    Leipzig, Germany · Recruiting

  • Klinikum rechts der Isar der Technischen Universität München

    München, Germany · Recruiting

  • GRN - Klinik Weinheim

    Weinheim, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.